ERD

ISIDORe | Integrated Services for Infectious Disease Outbreak Research

01-02-2022

-

31-07-2025

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

3TR | Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

01-09-2019

-

31-08-2026

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

IDEA-FAST | Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

01-11-2019

-

30-04-2026

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

CarrerasPathfinders | Enabling the next generation in search of blood cancer cures

01-09-2024

-

31-08-2029

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

CarrerasLeaders | Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

01-01-2023

-

31-12-2027

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

SAFE-N-MEDTECH | SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.

01-04-2019

-

30-09-2023

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

END-VOC | ENDING COVID 19 VARIANTS OF CONCERN THROUGH COHORT STUDIES: END-VOC

01-05-2022

-

30-04-2025

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

AVITHRAPID | Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases

01-01-2024

-

30-06-2028

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

FAIR-PARK-II | Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone

01-05-2015

-

31-10-2021

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

ISOBIOTICS | Isotopic Labeling of Biotherapeutics

01-02-2023

-

31-01-2027

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

BRAINTEASER | BRinging Artificial INTelligencE home for a better cAre of amyotrophic lateral sclerosis and multiple SclERosis

01-01-2021

-

31-12-2024

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

METHYLOMIC | DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.

01-01-2023

-

31-12-2026

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

MAGIC | Next-generation models and genetic therapies for rare neuromuscular diseases

01-06-2023

-

31-05-2027

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

ENDOTARGET | Systemic Endotoxemia as the driver of chronic inflammation - Biomarkers and novel therapeutic targets for Arthritis

01-01-2023

-

31-12-2026

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

OptiViVax | Optimising a High Efficacy Plasmodium vivax Malaria Vaccine

01-06-2023

-

31-05-2028

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

Cell2Cell | What makes a successfull pathogen? Understanding the impact of cell-to-cell heterogeneity in chromatin structure on infection and adaptation

01-11-2019

-

30-04-2024

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

ENLIGHT-TENplus | European Network Linking Informatics and Genomics of Helper T cells in Tissues

01-03-2021

-

28-02-2025

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

GLYCOVAX | A training network for the rational design of the next generation of well-defined glycoconjugate vaccines

01-11-2015

-

31-10-2019

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

ENLIGHT-TEN | European Network linking informatics and genomics of helper T cells

01-10-2015

-

30-09-2019

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

LysoMod | Genetic and Small Molecule Modifiers of Lysosomal Function

01-03-2017

-

31-08-2022

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

EvaMobs | Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform

01-01-2024

-

31-12-2028

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

INNO4COV-19 | Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance.

01-10-2020

-

30-11-2022

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

CANCERNA | RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY

01-06-2022

-

31-05-2025

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

INPACT | Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication.

01-02-2015

-

31-01-2019

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

TREGeneration | Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes

01-01-2015

-

31-12-2021

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

ProteinConjugates | A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates

01-11-2015

-

31-10-2019

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

SENATOR | Staff Exchange for Novel applications in 19f magnetic resonance imaging

01-05-2020

-

30-04-2024

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

Aqua-Synapse | The health benefits of deuterium depletion on synaptic function, regional metabolism, and behaviour

01-01-2023

-

31-12-2026

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

STRATA-FIT | Stratification of Rheumatoid Arthritis: CompuTational models to personalise mAnagement strategies for difFIcult-to-Treat disease

01-05-2023

-

30-04-2029

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

RiboMed | RNA in disease

01-09-2019

-

28-02-2023

Show more information

Organisation INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

Projects overview

Selected filters:

ISIDORe | Integrated Services for Infectious Disease Outbreak Research

3TR | Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

IDEA-FAST | Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

CarrerasPathfinders | Enabling the next generation in search of blood cancer cures

CarrerasLeaders | Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

SAFE-N-MEDTECH | SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.

END-VOC | ENDING COVID 19 VARIANTS OF CONCERN THROUGH COHORT STUDIES: END-VOC

AVITHRAPID | Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases

FAIR-PARK-II | Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone

ISOBIOTICS | Isotopic Labeling of Biotherapeutics

BRAINTEASER | BRinging Artificial INTelligencE home for a better cAre of amyotrophic lateral sclerosis and multiple SclERosis

METHYLOMIC | DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.

MAGIC | Next-generation models and genetic therapies for rare neuromuscular diseases

ENDOTARGET | Systemic Endotoxemia as the driver of chronic inflammation - Biomarkers and novel therapeutic targets for Arthritis

OptiViVax | Optimising a High Efficacy Plasmodium vivax Malaria Vaccine

Cell2Cell | What makes a successfull pathogen? Understanding the impact of cell-to-cell heterogeneity in chromatin structure on infection and adaptation

ENLIGHT-TENplus | European Network Linking Informatics and Genomics of Helper T cells in Tissues

GLYCOVAX | A training network for the rational design of the next generation of well-defined glycoconjugate vaccines

ENLIGHT-TEN | European Network linking informatics and genomics of helper T cells

LysoMod | Genetic and Small Molecule Modifiers of Lysosomal Function

EvaMobs | Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform

INNO4COV-19 | Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance.

CANCERNA | RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY

INPACT | Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication.

TREGeneration | Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes

ProteinConjugates | A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates

SENATOR | Staff Exchange for Novel applications in 19f magnetic resonance imaging

Aqua-Synapse | The health benefits of deuterium depletion on synaptic function, regional metabolism, and behaviour

STRATA-FIT | Stratification of Rheumatoid Arthritis: CompuTational models to personalise mAnagement strategies for difFIcult-to-Treat disease

RiboMed | RNA in disease